Inventor
GÜNTHER BERNHARD
DE26 patents
⚠️ This page may combine multiple inventors who share the name “GÜNTHER BERNHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVALIQ GMBH
19 patentsUS9770508B2Sep 26, 2017
Semifluorinated alkane compositions
NOVALIQ GMBH47 citations97
US10576154B2Mar 3, 2020
Semifluorinated alkane compositions
NOVALIQ GMBH17 citations94
US10555953B2Feb 11, 2020
Pharmaceutical composition for treatment of increased intraocular pressure
NOVALIQ GMBH15 citations94
US10449164B2Oct 22, 2019
Methods of treating ocular disorders using semifluorinated alkanes
NOVALIQ GMBH22 citations94
US10369117B2Aug 6, 2019
Compositions comprising mixtures of semifluorinated alkanes
NOVALIQ GMBH18 citations94
US10058615B2Aug 28, 2018
Semifluorinated alkane compositions
NOVALIQ GMBH26 citations94
US10273298B2Apr 30, 2019
Stabilized antibody compositions
NOVALIQ GMBH16 citations93
US9757460B2Sep 12, 2017
Stabilised protein compositions based on semifluorinated alkanes
NOVALIQ GMBH39 citations92
US12005033B2Jun 11, 2024
Compositions comprising mixtures of semifluorinated alkanes
NOVALIQ GMBH6 citations85
US11583513B2Feb 21, 2023
Semifluorinated alkane compositions
NOVALIQ GMBH10 citations85
US11324757B2May 10, 2022
Pharmaceutical composition for treatment of increased intraocular pressure
NOVALIQ GMBH7 citations85
US11987623B2May 21, 2024
Stabilized antibody compositions
NOVALIQ GMBH5 citations84
US11723861B2Aug 15, 2023
Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
NOVALIQ GMBH7 citations84
US11896559B2Feb 13, 2024
Opthalmic compositions comprising F6H8
NOVALIQ GMBH7 citations83
US11278503B2Mar 22, 2022
Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
NOVALIQ GMBH7 citations80
US11684589B2Jun 27, 2023
Pharmaceutical compositions for use in the therapy of blepharitis
NOVALIQ GMBH6 citations73
USRE49758EDec 19, 2023
Stabilised protein compositions based on semifluorinated alkanes
NOVALIQ GMBH0 citations61
US12569452B2Mar 10, 2026
Ophthalmic compositions comprising F6H8
NOVALIQ GMBH0 citations59
US12496326B2Dec 16, 2025
Ophthalmic composition for treatment of dry eye disease
NOVALIQ GMBH0 citations58
THEISINGER BASTIAN
5 patentsUS10045996B2Aug 14, 2018
Pharmaceutical composition for treatment of increased intraocular pressure
THEISINGER BASTIAN36 citations97
US9757459B2Sep 12, 2017
Liquid pharmaceutical composition for the delivery of active ingredients
THEISINGER BASTIAN45 citations97
US11160865B2Nov 2, 2021
Liquid pharmaceutical composition for the delivery of active ingredients
THEISINGER BASTIAN15 citations94
US10525062B2Jan 7, 2020
Pharmaceutical composition for treatment of increased intraocular pressure
THEISINGER BASTIAN16 citations94
US9968678B2May 15, 2018
Liquid pharmaceutical composition for the delivery of active ingredients
THEISINGER BASTIAN13 citations92